130 related articles for article (PubMed ID: 27477370)
1. New Zealand women's experience during their first year of Jadelle® contraceptive implant.
Roke C; Roberts H; Whitehead A
J Prim Health Care; 2016 Mar; 8(1):13-9. PubMed ID: 27477370
[TBL] [Abstract][Full Text] [Related]
2. A contraceptive subdermal implant releasing the progestin ST-1435: ovarian function, bleeding patterns, and side effects.
Laurikka-Routti M; Haukkamaa M
Fertil Steril; 1992 Dec; 58(6):1142-7. PubMed ID: 1459263
[TBL] [Abstract][Full Text] [Related]
3. Patient satisfaction with a levonorgestrel-releasing contraceptive implant. Reasons for and patterns of removal.
Haugen MM; Evans CB; Kim MH
J Reprod Med; 1996 Nov; 41(11):849-54. PubMed ID: 8951137
[TBL] [Abstract][Full Text] [Related]
4. The introduction of a new contraceptive; two years experience with Norplant.
Davie J; Hiremath K; Glasier A
Health Bull (Edinb); 1996 Jul; 54(4):314-7. PubMed ID: 8783485
[TBL] [Abstract][Full Text] [Related]
5. Prospective multicentre study comparing levonorgestrel implants with a combined contraceptive pill: final results.
Kirkman RJ; Bromham DR; O'Connor TP; Sahota JE
Br J Fam Plann; 1999 Jul; 25(2):36-40. PubMed ID: 10454652
[TBL] [Abstract][Full Text] [Related]
6. Twelve month follow-up of a contraceptive implant outreach service in rural Papua New Guinea.
Gupta S; Mola G; Ramsay P; Jenkins G; Stein W; Bolnga J; Black K
Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):213-218. PubMed ID: 28401563
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Discontinuation of Subdermal Levonorgestrel Implants (Jadelle) at the Lagos University Teaching Hospital, Lagos, Nigeria: An Analytic Cohort Study.
Ohazurike E; Olamijulo JA; Ibisomi L; Olorunfemi G; Oluwole AA
Afr J Reprod Health; 2020 Jun; 24(2):48-63. PubMed ID: 34077091
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of anembryonic pregnancy with use of levonorgestrel subdermal implant (JADELLE®): a case report.
Moutchia-Suh J; Mouemba DM; Ngwasiri CA
J Med Case Rep; 2018 Apr; 12(1):111. PubMed ID: 29704897
[TBL] [Abstract][Full Text] [Related]
9. A three-year comparative study of continuation rates, bleeding patterns and satisfaction in Australian women using a subdermal contraceptive implant or progestogen releasing-intrauterine system.
Weisberg E; Bateson D; McGeechan K; Mohapatra L
Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):5-14. PubMed ID: 24229367
[TBL] [Abstract][Full Text] [Related]
10. Effects of Jadelle used in Thai women aged between 20 and 45 years in King Chulalongkorn Memorial Hospital.
Laphikanont W; Taneepanichskul S
J Med Assoc Thai; 2006 Jun; 89(6):761-6. PubMed ID: 16850674
[TBL] [Abstract][Full Text] [Related]
11. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
12. Implant contraception in Singaporean women: one decade of experience in KK Women's and Children's Hospital.
Kang W; Tan KH
Singapore Med J; 2004 Oct; 45(10):482-6. PubMed ID: 15455169
[TBL] [Abstract][Full Text] [Related]
13. Transition from Norplant to Jadelle in a clinic with extensive experience providing contraceptive implants.
Brache V; Faundes A; Alvarez F; García AG
Contraception; 2006 Apr; 73(4):364-7. PubMed ID: 16531168
[TBL] [Abstract][Full Text] [Related]
14. Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study.
Short M; Dallay D; Omokanye S; Stauch K; Inki P
Eur J Contracept Reprod Health Care; 2014 Feb; 19(1):29-38. PubMed ID: 24289528
[TBL] [Abstract][Full Text] [Related]
15. Contraceptive implants.
McDonald-Mosley R; Burke AE
Semin Reprod Med; 2010 Mar; 28(2):110-7. PubMed ID: 20352560
[TBL] [Abstract][Full Text] [Related]
16. Levonorgestrel contraceptive implants in female patients 14 to 21 years old.
Suman VJ; Van Winter JT; Evans MP; Simmons PS; Jacobsen SJ; Manolis AL
Mayo Clin Proc; 1998 Jan; 73(1):10-6. PubMed ID: 9443673
[TBL] [Abstract][Full Text] [Related]
17. The levonorgestrel intrauterine system: cohort study to assess satisfaction in a postpartum population in Kenya.
Hubacher D; Masaba R; Manduku CK; Chen M; Veena V
Contraception; 2015 Apr; 91(4):295-300. PubMed ID: 25601351
[TBL] [Abstract][Full Text] [Related]
18. Jadelle subdermal implants. Preliminary experience in a teaching hospital in the Niger Delta Region of Nigeria.
Enyindah CE; Kasso T
Niger J Med; 2011; 20(2):270-4. PubMed ID: 21970242
[TBL] [Abstract][Full Text] [Related]
19. Bleeding complaints during the first year of norplant implants use and their impact on removal rate.
Diaz J; Faundes A; Olmos P; Diaz M
Contraception; 1996 Feb; 53(2):91-5. PubMed ID: 8838485
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of celecoxib on controlling irregular uterine bleeding secondary to Jadelle use.
Buasang K; Taneepanichskul S
J Med Assoc Thai; 2009 Mar; 92(3):301-7. PubMed ID: 19301720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
